Refuge is a cancer immunotherapy company leveraging synthetic biology and gene engineering to unlock the full promise of cell therapies. We create cell therapies that sense their surroundings and conditionally activate or repress multiple genes simultaneously – resulting in more potent and targeted treatments beyond a single target and function.
Total raised: $25M
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | 3E Biovent... | 3ebiovc.co... |
| - | DHVC | dh.vc |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 02.05.2018 | Series B | $25M | - | finsmes.co... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 03.05.2018 | Term Sheet... | TWO BANKRUPTCIES AND A WEDDING... | - | - | fortune.co... |
| 02.05.2018 | Refuge Bio... | Refuge Biotechnologies, Inc., ... | USA | - | finsmes.co... |
| 02.05.2018 | Refuge Bio... | MENLO PARK, CA, Refuge Biote... | - | - | vcnewsdail... |
| 02.05.2018 | Sequoia Ch... | Premium Venture capital firm ... | - | Mars W. Mo... | dealstreet... |
| 02.05.2018 | Chinese i... | A group of Chinese investors... | Financing | John Carro... | endpts.com... |